Sign In
Buy AXSM
$212.17
+1.13 (+0.535%)
At Close: Aug 04, 2026
Axsome (AXSM) Q2 Earnings Beat, Stock Dips on Pipeline Updates
10:40am, Tuesday, 08'th Aug 2023
Axsome (AXSM) incurs a narrower-than-expected loss in the second quarter. The company provides updates on its central nervous system candidates.
Axsome Therapeutics (AXSM) Reports Q2 Loss, Tops Revenue Estimates
09:53am, Monday, 07'th Aug 2023
Axsome Therapeutics (AXSM) came out with a quarterly loss of $1 per share versus the Zacks Consensus Estimate of a loss of $1.24. This compares to loss of $1.06 per share a year ago.
Axsome Therapeutics: 'Buy' The Auvelity Launch (Rating Upgrade)
06:09am, Sunday, 23'rd Jul 2023
Axsome Therapeutics' novel treatments for central nervous system disorders gain traction, with promising revenues from drugs Auvelity and Sunosi. Despite the current lack of profitability, Axsome show
The 3 Most Undervalued Biotech Stocks to Buy Now: July 2023
08:08am, Thursday, 20'th Jul 2023
The biotechnology sector is the reason why treatments and diagnostics for all mankind have experienced exponential advances. If you are passionate about value investing, you must understand that one o
Got $500? 3 Growth Stocks to Buy That Could Double Your Money
05:50am, Thursday, 13'th Jul 2023
Axsome Therapeutics' current drugs and pipeline programs look especially promising. Brookfield Renewable could double in six years if it hits the low end of its projected growth range.
Axsome (AXSM) Doses First Patient in Late-Stage ADHD Study
10:15am, Monday, 10'th Jul 2023
Axsome (AXSM) doses its first patient in the late-stage, label expansion study of solriamfetol for treating attention deficit hyperactivity disorder.
5 Top Stocks for July
05:45am, Saturday, 01'st Jul 2023
MercadoLibre and Axsome Therapeutics are two exciting growth stocks that are worth a look. NextEra Energy and Starbucks can afford to continue raising their dividends year after year.
Why Is Axsome Therapeutics (AXSM) Stock Down 10% Today?
10:08am, Wednesday, 28'th Jun 2023
Axsome Therapeutics (NASDAQ: AXSM ) stock is heading lower on Wednesday as investors react to the company pricing a public share offering. Axsome Therapeutics is selling 3 million shares of AXSM stock
2 Under-the-Radar Biotech Stocks to Buy in 2023
07:45am, Wednesday, 28'th Jun 2023
Axsome Therapeutics' exciting pipeline promises a bright future for the company. CRISPR Therapeutics is on the verge of what could be the first of many approvals.
3 Monster Stocks in the Making to Buy Right Now
06:07am, Sunday, 25'th Jun 2023
Axsome Therapeutics' pipeline features multiple potentially big winners. CRISPR Therapeutics could be at the beginning of a long-term success story.
3 Biotech Stocks to Buy as Companies Ink Major Deals
06:40am, Thursday, 22'nd Jun 2023
With patent expirations around the corner, some of the biggest pharmaceutical and biotech companies will soon face generic competition, creating a big opportunity for these top biotech stocks to buy.
Where Will Axsome Therapeutics Be in 3 Years?
08:23am, Tuesday, 20'th Jun 2023
Axsome's two new products are seeing prescription growth. The company aims to launch four more products in just a couple of years.
This Stock Crushed the Market Last Year. Here's Why It Could Do That Again.
02:00pm, Friday, 16'th Jun 2023
Axsome Therapeutics shares soared more than 100% last year after its first two products launched. It may have more on the way.
Axsome (AXSM) Soars 8.1%: Is Further Upside Left in the Stock?
04:01am, Thursday, 15'th Jun 2023
Axsome (AXSM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
3 No-Brainer Stocks to Buy in June
06:14am, Saturday, 10'th Jun 2023
Axsome Therapeutics is a rising star in biotech. Pfizer is too cheap to pass up.
